Clinical trials
Phase 3 Weight Loss trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 8 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Terminated | 7 |
| Not yet recruiting | 7 |
| Unknown status | 6 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital General Universitario Elche | 6 |
| InQpharm Group | 4 |
| Viking Therapeutics, Inc. | 4 |
| Eisai Inc. | 3 |
| Washington University School of Medicine | 3 |
| AstraZeneca | 2 |
| Kyle Flack | 2 |
| Mayo Clinic | 2 |
| Par Pharmaceutical, Inc. | 2 |
| Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weight Loss | 72 |
| Obesity | 40 |
| Overweight | 17 |
| Body Weight | 8 |
| Insulin Resistance | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Anorexia | 4 |
| Body Weight Changes | 4 |
| Cachexia | 4 |
| Hypertension | 4 |
Trials
Showing 26 to 50 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.